At a glance
ClinicalIndex Comparison RecordN/ACompleted· 754,745 enrolled
Drug / intervention
Exposure of venous thromboembolismother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Incidence of Venous Thromboembolism in Atopic Dermatitis: A Matched Cohort Analysis in UK Primary Care
In Brief
An observational study evaluating Exposure of venous thromboembolism for Venous Thromboembolism and 8 related conditions. Completed, enrolled 754,745 participants across 1 site.
Detailed Summary
This study aims to investigate the incidence of venous thromboembolism in people who are diagnosed with atopic dermatitis.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsVenous Thromboembolism, Atopic Dermatitis, Pulmonary Embolism, Deep Vein Thrombosis, Allergic Rhinitis, Allergy to House Dust Mite, Allergy to Animal Dander, Food Allergy, Cows Milk Allergy
CountriesUnited Kingdom
CollaboratorsPfizer
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartJun 2021
First PostedJul 2021
Primary CompletionMar 2023
Study CompletionJul 2023
TodayJul 2026
First PostedJul 21, 2021
Enrollment StartJun 21, 2021
Primary CompletionMar 31, 2023
Study CompletionJul 1, 2023
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 4.9 years ago
Interventions
Exposure of venous thromboembolismother
Composite of pulmonary embolism and deep vein thrombosis